The Human Guinea Pig Project

The Human Guinea Pig Project

Download on the App Store

The Human Guinea Pig Project episodes

  • Repurposing loperamide to target glioma, metabolic reprogramming, liquid biopsies.

    In this episode, recorded just before the New Year, I discuss recent news in brain cancer research.

    This includes:

    How the drug loperamide (brand name Imodium), induces cell death in glioblastoma cell lines and if this could have promise for real, human applications.

    Metabolic reprogramming via inhibition of a key cancer metabolite- D-2-Hydroxyglutarate (D-2-HG).

    Developments of liquid biopsies for glioma. 

    41 min
  • THGPP Episode 10: Meredith Moore- 15 year progression free survival of Glioblastoma Multiforme.

    This episode features long term GBM survivor and OurBrainBank board member Meredith Moore. We discuss the benefits of empowering patients to make informed choices about their treatment and how this has helped her to survive for 15 years and counting following a diagnosis of GBM in 2005.

    A large part of our conversation highlights patient advocacy and Meredith's involvement with OurBrainBank. OurBrainBank is an innovative, patient-led movement designed to move glioblastoma from terminal to treatable, powered by patients.

    1 hr 42 min
  • THGPP Episode 8: Dr Mithu Storoni- Managing stress and anxiety in the age of Covid-19.

    Mithu Storoni MD PhD is an author, physician, and researcher. She has undertaken research in Neuro-ophthalmology and Perceptual Neuroscience at Cambridge, in London and at Harvard Medical School. 

    Her book 'Stress Proof' seeks to provide practical, evidence based solutions to better manage the unique psychological challenges that modern life presents.

    In this episode of the podcast we discuss how to manage stress and anxiety in the age of Covid-19.

    1 hr 9 min
  • THGPP Episode 7: Marty Kendall- Optimising Nutrition

    Marty Kendall is a civil engineer with a strong passion for nutrition and founder of Optimising Nutrition https://optimisingnutrition.com. 

    From the experiences of helping his wife manage Type 1 diabetes and extensive research into optimal nutrition science, Marty has devised a number of programs and recipe books to help others achieve their nutrition goals with maximum micronutrient density, whatever form of diet they may choose to adopt. The main aim of these programs is to allow individuals to achieve stable blood sugar control with maximum nourishment.

    In this episode I discuss Marty's objective approaches to his Nutrient Optimisation programs as well as his new set of recipe books, available to download from the Optimising Nutrition website.

    1 hr 32 min
  • THGPP Episode 5: Nathan Delack- Cancer clusters- What can we learn from McCullom Lake?

    Nathan Delack is a 7-time EMMY-award-winning television news photojournalist.

    In this episode I interview Nathan on his upcoming documentary film about the McCullom Lake cancer cluster, chronicling the town’s search for answers and their fight for justice.

    LINKS:
    http://www.McCullomlake.net
    http://www.facebook.com/McCullomLake
    http://www.Twtitter.com/McCullomLake

    Background:

    In 2014, residents of McCullom Lake, Illinois, settled an eight-year-old lawsuit in which they claimed exposure to vinyl chloride and other volatile organic compounds from a nearby Dow Chemical plant had caused a brain cancer cluster in the area. 

    The original lawsuits also named the neighbouring Modine Manufacturing plant, alleging that its contribution of trichloroethylene to the plume made it culpable for illnesses. Modine settled with the plaintiffs in 2008 for undisclosed amounts.

    The village of McCullom lake has a population of just over 1,000 residents. A brain cancer cluster of 33 brain tumours was reported at the time, with many more people thought to be affected following further investigation.

    36 min
  • THGPP Episode 3: Tristan Haggard- What's going on with our food system?

    Tristan founded Primal Edge Health with his wife Jessica in 2014 as a means to explore the cutting edge of holistic lifestyle optimisation. They share knowledge on animal-based nutrition, the ketogenic and carnivore diets, whole unrefined ancestral foods, regenerative agriculture, and homesteading as part of their mission to build healthy bodies, homes, families and communities.

    You can follow Primal Edge Health on Youtube, Instagram, Twitter and Facebook where they share the latest ketogenic recipes, research, and critique big business, anti-health propaganda.:

    Youtube- https://www.youtube.com/primaledgehealth

    Instagram- https://www.instagram.com/primaledgeh...

    Twitter- https://twitter.com/TristanHaggard

    Facebook- https://www.facebook.com/PrimalEdgeHe...

    1 hr 37 min
  • THGPP Episode 4: Brent Wagner MD- Gadolinium based contrast agents. Are they safe?

    Dr. Wagner is a clinical nephrologist. He is the Director of the Kidney Institute of New Mexico as well as being the acting Associate Chief of Research and Renal Section Chief for the VA in Albuquerque.

    In this episode we discuss recent evidence urging caution over the use of gadolinium based contrast agents.

    To fund Dr. Wagner’s work you can donate to the Kidney Institute of New Mexico at

    https://www.unmfund.org/fund/unm-kidn...

    Links:

    Reveal Pharmaceuticals, Gadolinium-free MRI contrast agents products.

    http://www.revealpharma.com

    Peter Caravan PhD. Director, Institute for Innovation in Imaging Massachusetts and Associate Professor of Radiology at Harvard Medical School.

    Twitter- @PeterCaravan


    The FDA adverse event reporting system

    https://open.fda.gov/data/faers/

    Gadolinium-based contrast agents: why nephrologists need to be concerned

    https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6416778/

    42 min

About The Human Guinea Pig Project

From the publisher's feed

The Human Guinea Pig Project is a podcast series where individuals discuss alternative methods of managing complex medical conditions and disease where the standard of care offers little promise.